• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home The Classics Emergency Classics

The CORTICUS trial: Hydrocortisone in septic shock [Classics Series]

byAndrew Cheung, MD MBA
June 26, 2013
in Emergency Classics, General Medicine Classics, The Classics
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. There was no significant difference in mortality between patients with septic shock receiving low-dose hydrocortisone compared to placebo

2. Hydrocortisone therapy reversed shock more quickly, but resulted in more cases of superinfection

Original Date of Publication: January 10, 2008

Study Rundown: Recommendations that patients with septic shock be treated with low-dose corticosteroids were based on a limited set of evidence and largely dependent on one larger trial. Although insufficiently powered, the CORTICUS study was the largest trial to date investigating the use of hydrocortisone in patients with septic shock. The results of the study point to an absence of effect of hydrocortisone therapy in patients with septic shock and suggest that response to a corticotropin test is not a useful prognostic factor for response to hydrocortisone.

In sum, hydrocortisone therapy did not reduce mortality in this group of patients with septic shock and therapy may be associated with increased incidence of superinfection. Response to a corticotropin test did not indicate which patients were more likely to respond to hydrocortisone therapy.

Please click to read study in NEJM

RELATED REPORTS

Early restrictive fluid management does not reduce mortality in sepsis-induced hypotension

Balanced intravenous solutions reduce risk of hyperchloremia in the pediatric intensive care unit

#VisualAbstract: Restriction of Intravenous Fluids in ICU Patients with Septic Shock

In-Depth [randomized, controlled study]: In this randomized controlled trial, published in NEJM in 2008, 499 patients with septic shock were randomly assigned to receive low-dose hydrocortisone therapy or placebo. All patients were assessed for a response to a corticotropin test. The primary end point was the rate of death at 28 days in patients without a response to corticotropin. There was no significant difference in the primary outcome between the hydrocortisone and placebo groups. There was also no significant difference in the rate of death at 28 days in patients who responded to corticotropin, nor was there a significant difference in overall deaths between the two study groups. Time to reversal of shock was shorter in the hydrocortisone group than the placebo group (3.3 days versus 5.8 days for all patients). There was a higher incidence of superinfections in the hydrocortisone group, including new episodes of sepsis and septic shock.

By Adrienne Cheung, Andrew Cheung, M.D.

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. Content is produced in accordance with fair use copyrights solely and strictly for the purpose of teaching, news and criticism. No benefit, monetary or otherwise, is realized by any participants or the owner of this domain.

Tags: corticuscorticus trialcortisonesepsisseptic shock
Previous Post

Preventable ED visits by top spenders are a small proportion of Medicare costs

Next Post

Lifestyle intervention in obese diabetics does not affect cardiovascular events

RelatedReports

Hypotonic IVF linked to increased risk of hyponatremia
Chronic Disease

Early restrictive fluid management does not reduce mortality in sepsis-induced hypotension

February 17, 2023
Hypotonic IVF linked to increased risk of hyponatremia
Emergency

Balanced intravenous solutions reduce risk of hyperchloremia in the pediatric intensive care unit

January 5, 2023
#VisualAbstract: Restriction of Intravenous Fluids in ICU Patients with Septic Shock
StudyGraphics

#VisualAbstract: Restriction of Intravenous Fluids in ICU Patients with Septic Shock

July 8, 2022
#VisualAbstract: Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients
StudyGraphics

#VisualAbstract: Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients

July 7, 2022
Next Post
Lifestyle intervention in obese diabetics does not affect cardiovascular events

Lifestyle intervention in obese diabetics does not affect cardiovascular events

New mutations behind heritable hypercalcemia and hypocalcemia identified

New mutations behind heritable hypercalcemia and hypocalcemia identified

Neoadjunctive radiotherapy, hospital factors key for rectal cancer resection

Neoadjunctive radiotherapy, hospital factors key for rectal cancer resection

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Mycobacterium abscessus infections after cardiac surgery linked to hospital water system
  • The 2 Minute Medicine Podcast Episode 11
  • Wellness Check: Spirituality
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options